Clinical Trials
Clinical trials involving the administration of infectious agents or recombinant or synthetic nucleic acids to human study participants requires review and approval by the IBC.
The Biohazard Warning Sign must be affixed to entry doors of the following laboratories/rooms:
BSL-2 with BSL-3 practices labs with approved decontamination procedures to lower containment to BSL-2 must follow the posting requirements in their laboratory-specific standard operating procedures (SOPs).
How to Complete the Biohazard Warning Sign:
Pressure vessels, autoclaves and
The Empty Chemical Containers Focus Sheet provides guidance to dispose of or reuse chemical containers in accordance with hazardous waste regulations.